Transplacental pharmacokinetics and fetal distribution of 2',3'-didehydro-3'-deoxythymidine (d4T) and its metabolites in late-term rhesus macaques

Teratology

Volumn 62, Issue 2, 2000, Pages 93-99

  Patterson, Tucker A ^a   Binienda, Zbigniew K ^a   Newport, Glenn D ^a   Lipe, George W ^a   Gillam, Michael P ^a   Slikker Jr , William ^a   Sandberg, Jennifer A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAVUDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; FETUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; KIDNEY; NONHUMAN; PLACENTAL TRANSFER; PRIORITY JOURNAL; RHESUS MONKEY;

AMINOISOBUTYRIC ACIDS; ANIMALS; ANTI-HIV AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FETUS; KIDNEY; MACACA MULATTA; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; STAVUDINE; THYMINE; TIME FACTORS; TISSUE DISTRIBUTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA MULATTA;

EID: 0033862908     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9926(200008)62:2<93::AID-TERA5>3.0.CO;2-M     Document Type: Article

References (21)

1. Bawdon RE, Kaul S, Sobhi S. 1994. The ex vivo transfer of the anti-HIV nucleoside compound d4T in the human placenta. Gynecol Obstet Invest 38:1-4.
2. Browne MJ, Mayer KH, Chafee SBD, Dudley MN, Posner MR, Steinberg SM, Graham KK, Geletko SM, Zinner SH, Denman SL, Dunkle LM, Kaul S, McLaren C, Skowron G, Kouttab NM, Kennedy TA, Weitberg AB, Curt GA. 1993. 2′,3′-didehydro-3′-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial. J Infect Dis 167:21-29.
3. Cao Y, Krogstad P, Korber BT, Koup RA, Muldoon M, Macken C, Song JL, Jin Z, Zhao JQ, Clapp S, Chen ISY, Ho DD, Ammann AJ, the Ariel Project Investigators. 1997. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nature Med 3:549-552.
4. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy J-F, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331:1173-1180.
5. Cretton EM, Zhou Z, Kidd LB, McClure HM, Kaul S, Hitchcock MJM, Sommadossi JP. 1993. In vitro and in vivo disposition and metabolism of 3′-deoxy-2′,3′-didehydrothymidine. Antimicrob Agents Chemother 37:1816-1825.
6. Dudley, MN, Graham KK, Kaul S, Geletko S, Dunkle L, Browne M, Mayer K. 1992. Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex. J Infect Dis 166:480-485.
7. Ho H-T, Hitchcock MJM. 1989. Cellular pharmacology of 2′,3′-dideoxy-2′,3′-didehydrothymidine, a nucleoside analogue active against human immunodeficiency virus. Antimicrob Agents Chemother 33:844-849.
8. Izuta S, Saneyoshi M, Sakurai T, Suzuki M, Kojima K, Yoshida S. 1991. The 5′-triphosphates of 3′-azido-3′-deoxythymidine and 2′,3′dideoxynucleosides inhibit DNA polymerase γ by different mechanisms. Biochem Biophys Res Commun 179:776-783.
9. Kaul S, Dandekar KA. 1993. Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys. Antimicrob Agents Chemother 37:1160-1162.
10. Liebes L, Mendoza S, Lee JD, Dancis J. 1993. Further observations of zidovudine transfer and metabolism by human placenta. AIDS 7:590-592.
11. Lin T-S, Schinazi RF, Prusoff WH. 1987. Potent and selective in vitro activity of 3′-deoxythymidin-2′-ene (3′-deoxy-2′,3′-didehydrothymidine) against human immunodeficiency virus. Biochem Pharmacol 36:2713-2718.
12. Matthes E, Lehmann Ch, Scholz D, von Janta-Lipinski M, Gaertner K, Rosenthal HA, Langen P. 1987. Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5′-triphosphate in comparison to cellular DNA polymerases α and β. Biochem Biophys Res Commun 148:78-85.
13. Mitsuya H, Yarchoan R, Broder S. 1990. Molecular targets for AIDS therapy. Science 249:1533-1544.
14. Odinecs A, Nosbisch C, Keller RD, Baughman WL, Unadkat JD. 1996a. In vivo maternal-fetal pharmacokinetics of stavudine (2′,3′-didehydro-3′-deoxythymidine) in pigtailed macaques (Macaca nemestrina). Antimicrob Agents Chemother 40:196-202.
15. Odinecs A, Pereira C, Nosbisch C, Unadkat JD. 1996b. Prenatal and postpartum pharmacokinetics of stavudine (2′,3′-didehydro-3′-deoxythymidine) and didanosine (dideoxyinosine) in pigtailed macaques (Macaca nemestrina). Antimicrob Agents Chemother 40: 2423-2425.
16. Patterson TA, Binienda Z, Lipe GW, Gillam MP, Slikker W Jr, Sandberg JA. 1997. Transplacental pharmacokinetics and fetal distribution of azidothymidine (AZT), its glucuronide (AZTG), and phosphorylated metabolites in late-term rhesus macaques after maternal infusion. Drug Metab Dispos 25:453-459.
17. Qian M, Bui T, Ho RJY, Unadkat JD. 1994. Metabolism of 3′-azido-3′-deoxy-thymidine (AZT) in human placental trophoblasts and Hofbauer cells. Biochem Pharmacol 48:383-389.
18. Sandberg JA, Binienda Z, Lipe G, Rose LM, Parker WB, Ali SF, Slikker W Jr. 1995. Placental transfer and fetal disposition of 2′,3′-dideoxycytidine (ddC) and 2′,3′-dideoxyinosine (ddI) in the rhesus monkey. Drug Metab Dispos 23:881-884.
19. Schinazi RF, Boudinot FD, Doshi KJ, McClure HM. 1990. Pharmacokinetics of 3′-fluoro-3′-deoxythymidine and 3′-deoxy-2′,3′-didehydrothymidine in rhesus monkeys. Antimicrob Agents Chemother 34:1214-1219.
20. Sommadossi JP. 1995. Comparison of metabolism and in vitro antiviral activity of stavudine versus other 2′,3′-dideoxynucleoside analogues. J Infect Dis 171[suppl 2]:S88-S92.
21. Zhu Z, Ho H-T, Hitchcock MJ, Sommadossi J-P. 1990. Cellular pharmacology of 2′,3′-didehydro-2′,3′-dideoxythymidine (d4T) in human peripheral blood mononuclear cells. Biochem Pharmacol 39:R15-R19.